← Back to Search

Pre-Visit Planner (PVP) + MyChart for Lung Cancer (ELFE Trial)

N/A

Recruiting

Research Sponsored by University of California, Davis

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 156 weeks

Awards & highlights

ELFE Trial Summary

"This trial aims to learn more about what helps to encourage more people to get screened for lung cancer."

Who is the study for?

This trial is for patients aged 50-80 who are eligible for lung cancer screening, have a history of smoking, and receive care at specified UCDH clinics. It's also for UCDH primary care providers and staff. People under 49, non-UCDH staff, those already screened for lung cancer, non-consenting individuals or those not fluent in English or Spanish, and patients with existing cancer cannot join.Check my eligibility

What is being tested?

The study aims to understand how to improve lung cancer screening rates by testing two approaches: a 'Pre-Visit Planner' tool alone versus the planner combined with 'MyChart', an electronic health record system. The effectiveness of these interventions in increasing screenings will be compared.See study design

What are the potential side effects?

Since this trial involves informational tools rather than medical treatments or drugs, there are no direct physical side effects associated with participating. However, participants may experience inconvenience or require additional time commitment.

ELFE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 156 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~156 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 156 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Lung Cancer Screening

Secondary outcome measures

Completion of Interviews with Staff and Patients

ELFE Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Pre-Visit Planner (PVP) + MyChartExperimental Treatment1 Intervention

A Licensed Vocational Nurse (LVN) will verify patient smoking history and calculate pack years with the patient over the phone. In addition, the patient will receive educational video through MyChart prior to an LVN calling.

Group II: Pre-Visit Planner (PVP)Experimental Treatment1 Intervention

A Licensed Vocational Nurse (LVN) will verify patient smoking history and calculate pack years with the patient over the phone.

Group III: Usual CareActive Control1 Intervention

Patients will receive usual care.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor

911 Previous Clinical Trials

4,706,650 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What specific criteria must individuals meet to be eligible for enrollment in this clinical study?

"To qualify for participation in this study, individuals must have a diagnosis of lung carcinoma and fall within the age bracket of 50 to 80 years. The trial aims to enroll approximately 2869 eligible participants into its research cohort."

Answered by AI

How many individuals are participating in the entirety of this research study?

"Indeed, the details available on clinicaltrials.gov affirm that this research endeavor is actively pursuing potential participants. The trial was initially published on November 10th, 2022 and its latest update occurred on April 1st, 2024. Approximately 2869 patients are sought from a singular site for inclusion in this study."

Answered by AI

Is the study open to individuals aged 55 and above?

"Participants entering this study must fall within the age bracket of 50 to 80 years. Notably, there are a substantial number of trials available for both pediatric patients under 18 and older adults over the age of 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Enhancing Lung Cancer Screening Through Human-Centered Intervention

Moon S. Chen,Jr. PhD,MPH 2022. "Enhancing Lung Cancer Screening Through Human-Centered Intervention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06351085.

All > Sacramento